JOAQUÍN
DÍAZ MEDIAVILLA
Investigador hasta 2014
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (77)
2016
-
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia
Leukemia Research, Vol. 40, pp. 1-9
2015
-
Asociación de la hemoglobina Groene Hart con la hemoglobina J-París-I: primer caso en España
Medicina Clinica, Vol. 144, Núm. 5, pp. 212-215
-
Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia
Annals of Hematology, Vol. 94, Núm. 8
2014
-
Hb Cibeles [α2 CD25(B6) (Gly → Asp)]: a novel alpha chain variant causing alpha-thalassemia
International Journal of Hematology, Vol. 100, Núm. 6, pp. 599-601
2013
-
A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control
Leukemia, Vol. 27, Núm. 10, pp. 2056-2061
-
Association in cis of the mutations +20 (C>T) in the 5′ untranslated region and IVS-II-745 (C>G) on the β-globin gene
Hemoglobin, Vol. 37, Núm. 2, pp. 112-118
-
Erythrocytosis in a child due to Hb andrew-minneapolis [β144(HC1) Lys→Asn (AAG>AAT or AAC)] associated with a Spanish (δβ) ;0-thalassemia
Hemoglobin, Vol. 37, Núm. 1, pp. 48-55
2012
-
Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease
Haematologica, Vol. 97, Núm. 4, pp. 616-621
-
High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
Blood, Vol. 119, Núm. 3, pp. 687-691
-
Multiparameter flow cytometry evaluation of plasma cell DNA content and proliferation in 595 transplant-eligible patients with myeloma included in the Spanish GEM2000 and GEM2005<65y trials
American Journal of Pathology, Vol. 181, Núm. 5, pp. 1870-1878
-
Study of three families with Hb agrinio [α29(B10)Leu→Pro, CTG>CCG (α2)] in the spanish population: Three homozygous cases
Hemoglobin, Vol. 36, Núm. 6, pp. 526-532
-
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: A randomized phase 3 PETHEMA/GEM study
Blood, Vol. 120, Núm. 8, pp. 1589-1596
2011
-
Hb extremadura [β64(E8)Gly→Ser;β133(H11)Val→Leu]: A new molecular analysis
Hemoglobin, Vol. 35, Núm. 4, pp. 423-427
-
Invasive fungal infections in onco-haematology: A spanish perspective
Revista Espanola de Quimioterapia, Vol. 24, Núm. 3, pp. 168-172
-
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance
Blood, Vol. 118, Núm. 17, pp. 4547-4553
-
Recomendaciones para el tratamiento de las infecciones f́ngicas invasoras causadas por hongos filamentosos en pacientes hematológicos
Revista Espanola de Quimioterapia, Vol. 24, Núm. 4, pp. 263-270
2010
-
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)
Annals of Hematology, Vol. 89, Núm. 5, pp. 453-458
-
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study
Haematologica, Vol. 95, Núm. 11, pp. 1913-1920
-
Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients
Haematologica, Vol. 95, Núm. 5, pp. 745-751
-
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: Further improvements in treatment outcome
Blood, Vol. 115, Núm. 25, pp. 5137-5146